N. Hughes

Use of DNA microarray and small animal positron emission tomography in preclinical drug evaluation of RAF265, a novel B-Raf/VEGFR-2 inhibitor.

S. Gambhir, D. Stuart, Jeffrey R. Tseng, 2011, Neoplasia.

Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment

A. Harris, A. Padhani, A. Makris, 2016, EBioMedicine.

Survival and Death Signals Can Predict Tumor Response to Therapy After Oncogene Inactivation

Lawrence H. Schwartz, Nicholas P. Hughes, Dean W. Felsher, 2011, Science Translational Medicine.

Robust Estimation of Pharmacokinetic Modelling Parameters for the Analysis of Colorectal Tumours

F. Gleeson, S. M. Brady, M. Anderson, 2015 .

A blood biomarker for monitoring response to anti-EGFR therapy.

Sharon S. Hori, S. Gambhir, C. H. Nielsen, 2018, Cancer biomarkers : section A of Disease markers.

Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles.

Andreas Makris, Adrian L Harris, Francesca M Buffa, 2011, Journal of the National Cancer Institute. Monographs.

Title Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location Permalink

E. Graves, A. Giaccia, M. Vilalta, 2018 .

Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location

E. Graves, A. Giaccia, M. Vilalta, 2017, Molecular Imaging and Biology.

Oncogene Inactivation Survival and Death Signals Can Predict Tumor Response to Therapy After

L. Schwartz, D. Paik, D. Felsher, 2011 .